In vivo short-term precision of hip comparison with bone mineral density structure analysis variables in using paired dual-energy X-ray absorptiometry scans from multi-center clinical trials

被引:117
作者
Khoo, BCC [1 ]
Beck, TJ
Qiao, QH
Parakh, P
Semanick, L
Prince, RL
Singer, KP
Price, RI
机构
[1] Sir Charles Gairdner Hosp, Dept Med Technol & Phys, Nedlands, WA 6009, Australia
[2] Western Australian Inst Med Res, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Sch Surg & Pathol, Ctr Musculoskeletal Studies, Perth, WA 6000, Australia
[4] Johns Hopkins Outpatient Ctr, Dept Radiol, Baltimore, MD 21287 USA
[5] Univ Western Australia, Dept Med, Perth, WA 6009, Australia
关键词
hip structural analysis; precision; dual-energy X-ray absorptiometry; bone mineral density;
D O I
10.1016/j.bone.2005.03.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hip structural analysis (HSA) is a technique for extracting strength-related structural dimensions of bone cross-sections from two-dimensional hip scan images acquired by dual energy X-ray absorptiometry (DXA) scanners. Heretofore the precision of the method has not been thoroughly tested in the clinical setting. Using paired scans from two large clinical trials involving a range of different DXA machines, this study reports the first precision analysis of HSA variables, in comparison with that of conventional bone mineral density (BMD) on the same scans. A key HSA variable, section modulus (Z), biomechanically indicative of bone strength during bending, had a short-term precision percentage coefficient of variation (CV%) in the femoral neck of 3.4-10.1%, depending on the manufacturer or model of the DXA equipment. Cross-sectional area (CSA), a determinant of bone strength during axial loading and closely aligned with conventional DXA bone mineral content, had a range of CV% from 2.8% to 7.9%. Poorer precision was associated with inadequate inclusion of the femoral shaft or femoral head in the DXA-scanned hip region. Precision of HSA-derived BMD varied between 2.4% and 6.4%. Precision of DXA manufacturer-derived BNID varied between 1.9% and 3.4%, arising from the larger analysis region of interest (ROI). The precision of HSA variables was not generally dependent on magnitude, subject height, weight, or conventional femoral neck densitometric variables. The generally poorer precision of key HSA variables in comparison with conventional DXA-derived BNID highlights the critical roles played by correct limb repositioning and choice of an adequate and appropriately positioned ROI. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:112 / 121
页数:10
相关论文
共 25 条
[1]   Structural adaptation to changing skeletal load in the progression toward hip fragility: The study of osteoporotic fractures [J].
Beck, TJ ;
Oreskovic, TL ;
Stone, KL ;
Ruff, CB ;
Ensrud, K ;
Nevitt, MC ;
Genant, HK ;
Cummings, SR .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (06) :1108-1119
[2]   Structural trends in the aging femoral neck and proximal shaft: Analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data [J].
Beck, TJ ;
Looker, AC ;
Ruff, CB ;
Sievanen, H ;
Wahner, HW .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (12) :2297-2304
[3]  
BECK TJ, OSTEOPOROSIS, P885
[4]   Structure of the femoral neck in hip fracture: Cortical bone loss in the inferoanterior to superoposterior axis [J].
Bell, KL ;
Loveridge, N ;
Power, J ;
Garrahan, N ;
Stanton, M ;
Lunt, M ;
Meggitt, BF ;
Reeve, J .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (01) :111-119
[5]   Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[6]   BONE-MINERAL CONTENT OF THE FEMORAL-NECK AND SHAFT - RELATION BETWEEN CORTICAL AND TRABECULAR BONE [J].
BOHR, H ;
SCHAADT, O .
CALCIFIED TISSUE INTERNATIONAL, 1985, 37 (04) :340-344
[7]   Effects of anteversion on femoral bone mineral density and geometry measured by dual energy X-ray absorptiometry: A cadaver study [J].
Cheng, XG ;
Nicholson, PHF ;
Boonen, S ;
Brys, P ;
Lowet, G ;
Nijs, J ;
Dequeker, J .
BONE, 1997, 21 (01) :113-117
[8]   Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial [J].
Delmas, PD ;
Ensrud, KE ;
Adachi, JD ;
Harper, KD ;
Sarkar, S ;
Gennari, C ;
Reginster, JY ;
Pols, HAP ;
Recker, RR ;
Harris, ST ;
Wu, WT ;
Genant, HK ;
Black, DM ;
Eastell, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3609-3617
[9]  
GERE JM, 2003, MECH MATER, P323
[10]  
Girard M S, 1994, Orthop Rev, V23, P38